[HTML][HTML] Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - Springer
Background Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - hero.epa.gov
BACKGROUND: Tissue-engineered bone may be developed by seeding the cells capable
of both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

[PDF][PDF] Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - Citeseer
Background: Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

Biocompatibility of Poly-epsilon-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells.

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - europepmc.org
Background Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - 2009 - digitalcommons.wayne.edu
Background Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

[PDF][PDF] Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - researchgate.net
Background: Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

[PDF][PDF] Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - cyberleninka.org
Background: Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

[HTML][HTML] Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - ncbi.nlm.nih.gov
Background Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

[PDF][PDF] Biocompatibility of Poly-ε-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - scienceopen.com
Background: Tissue-engineered bone may be developed by seeding the cells capable of
both osteogenesis and vascularization on biocompatible composite scaffolds. The current …

Biocompatibility of Poly-[epsilon]-caprolactone-hydroxyapatite composite on mouse bone marrow-derived osteoblasts and endothelial cells

H Yu, PH Wooley, SY Yang - Journal of Orthopaedic Surgery and …, 2009 - go.gale.com
Background One approach to tissue engineering consists of seeding appropriate cells on a
biodegradable scaffold, stimulating cell growth and differentiation in vitro, and then …